EPS Value Plus backs CHF 10m round in Sensimed

Existing investors Wellington Partners, Vinci Capital and BlueOcean Ventures also participated in the funding round. EPS Value Plus provided the funding from its listed investment fund New Value AG.

The new capital will be used to achieve approval in the US and in Asian countries, to commercialise the device in selected geographies, to run post-marketing application trials and to fund ongoing operations.

Lausanne-based Sensimed was founded in 2003 as a spin-off of Ecole Polytechnique Federale de Lausanne and is focussing on designing, developing and commercialising integrated micro-systems for medical devices.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Emanuel Eftimiu on +44 20 7004 7464 or emanuel.eftimiu@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH
• Healthcare
• Switzerland
• Wellington Partners